462 related articles for article (PubMed ID: 33883875)
1. Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy.
Hawkins ER; D'Souza RR; Klampatsa A
Biologics; 2021; 15():95-105. PubMed ID: 33883875
[TBL] [Abstract][Full Text] [Related]
2. Befriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy.
Lindo L; Wilkinson LH; Hay KA
Front Immunol; 2020; 11():618387. PubMed ID: 33643299
[TBL] [Abstract][Full Text] [Related]
3. CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment.
Martinez M; Moon EK
Front Immunol; 2019; 10():128. PubMed ID: 30804938
[TBL] [Abstract][Full Text] [Related]
4. Armored TGFβRIIDN ROR1-CAR T cells reject solid tumors and resist suppression by constitutively-expressed and treatment-induced TGFβ1.
Tran TM; Chand Thakuri BK; Nurmukhambetova S; Lee JJ; Hu P; Tran NQ; Steimle B; Dash P; Schneider D
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38609317
[TBL] [Abstract][Full Text] [Related]
5. Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy.
Yeku OO; Brentjens RJ
Biochem Soc Trans; 2016 Apr; 44(2):412-8. PubMed ID: 27068948
[TBL] [Abstract][Full Text] [Related]
6. Chimeric antigen receptor-engineered T-cell therapy for liver cancer.
Chen Y; E CY; Gong ZW; Liu S; Wang ZX; Yang YS; Zhang XW
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):301-309. PubMed ID: 29861325
[TBL] [Abstract][Full Text] [Related]
7. Evolving CAR-T-Cell Therapy for Cancer Treatment: From Scientific Discovery to Cures.
Majumder A
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201467
[TBL] [Abstract][Full Text] [Related]
8. Target selection of CAR T cell therapy in accordance with the TME for solid tumors.
Liu B; Yan L; Zhou M
Am J Cancer Res; 2019; 9(2):228-241. PubMed ID: 30906625
[TBL] [Abstract][Full Text] [Related]
9. Gene modification strategies for next-generation CAR T cells against solid cancers.
Tian Y; Li Y; Shao Y; Zhang Y
J Hematol Oncol; 2020 May; 13(1):54. PubMed ID: 32423475
[TBL] [Abstract][Full Text] [Related]
10. Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment.
Yeku OO; Purdon TJ; Koneru M; Spriggs D; Brentjens RJ
Sci Rep; 2017 Sep; 7(1):10541. PubMed ID: 28874817
[TBL] [Abstract][Full Text] [Related]
11. CAR-T cell therapy in melanoma: A future success story?
Simon B; Uslu U
Exp Dermatol; 2018 Dec; 27(12):1315-1321. PubMed ID: 30288790
[TBL] [Abstract][Full Text] [Related]
12. Manipulating the tumor microenvironment by adoptive cell transfer of CAR T-cells.
Gowrishankar K; Birtwistle L; Micklethwaite K
Mamm Genome; 2018 Dec; 29(11-12):739-756. PubMed ID: 29987406
[TBL] [Abstract][Full Text] [Related]
13. Superkine IL-2 and IL-33 Armored CAR T Cells Reshape the Tumor Microenvironment and Reduce Growth of Multiple Solid Tumors.
Brog RA; Ferry SL; Schiebout CT; Messier CM; Cook WJ; Abdullah L; Zou J; Kumar P; Sentman CL; Frost HR; Huang YH
Cancer Immunol Res; 2022 Aug; 10(8):962-977. PubMed ID: 35696724
[TBL] [Abstract][Full Text] [Related]
14. Development of CAR T cells designed to improve antitumor efficacy and safety.
Jaspers JE; Brentjens RJ
Pharmacol Ther; 2017 Oct; 178():83-91. PubMed ID: 28342824
[TBL] [Abstract][Full Text] [Related]
15. A Metabolism Toolbox for CAR T Therapy.
Xu X; Gnanaprakasam JNR; Sherman J; Wang R
Front Oncol; 2019; 9():322. PubMed ID: 31114756
[TBL] [Abstract][Full Text] [Related]
16. Programming CAR T cells to enhance anti-tumor efficacy through remodeling of the immune system.
Wang X; Wu Z; Qiu W; Chen P; Xu X; Han W
Front Med; 2020 Dec; 14(6):726-745. PubMed ID: 32794014
[TBL] [Abstract][Full Text] [Related]
17. Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for Glioblastoma.
Pawlowski KD; Duffy JT; Gottschalk S; Balyasnikova IV
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136398
[TBL] [Abstract][Full Text] [Related]
18. Prospects and challenges for use of CAR T cell therapies in solid tumors.
Ramakrishna S; Barsan V; Mackall C
Expert Opin Biol Ther; 2020 May; 20(5):503-516. PubMed ID: 32125191
[No Abstract] [Full Text] [Related]
19. Chimeric antigen receptor T cells in solid tumors: a war against the tumor microenvironment.
Zhao Z; Xiao X; Saw PE; Wu W; Huang H; Chen J; Nie Y
Sci China Life Sci; 2020 Feb; 63(2):180-205. PubMed ID: 31883066
[TBL] [Abstract][Full Text] [Related]
20. Emerging Novel Combined CAR-T Cell Therapies.
Nguyen A; Johanning G; Shi Y
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
